Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Regulatory News (GIF)

  • This share is currently suspended. It was suspended at a price of 2.26
  • There is currently no data for GIF

Time-scheduled buy-back programme

22 Feb 2017 07:00

RNS Number : 4744X
Qatar Investment Fund PLC
22 February 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

22 February 2017

Qatar Investment Fund plc

("QIF" or the "Company")

Announcement of Time-Scheduled Buy-Back Programme

The Company today announces a time-scheduled buy-back programme in accordance with Commission Delegated Regulation (EU) 2016/1052 dated 8 March 2016 supplementing Regulation (EU) No 596/2014.

The ordinary share buy-back programme (the "Programme") has the sole purpose of reducing the issued ordinary share capital of the Company and as shares will not be acquired above the prevailing net asset value per share, it is also expected to enhance its Net Asset Value ("NAV") per share.

The Programme will commence with effect from today and will end, unless terminated earlier, on 17 November 2017. The Programme will be conducted in accordance with the authorisation granted to the Company by shareholders at the Annual General Meeting ("AGM") held on 18 November 2016 and the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014, to buy back up to 17,548,355 ordinary shares (being the equivalent of 14.99% of the Company's issued share capital at the date of the AGM notice). The maximum amount of money allocated to the Programme is $1,000,000.

Prior to the commencement of the Programme, the Company has effected share buy-backs under the authority granted by shareholders at the AGM on 18 November 2016 and has bought back a total of 234,832 ordinary shares.

Pursuant to, and during the term of, the Programme, the Company may purchase Ordinary Shares provided that:

1) the maximum price payable for an ordinary share on the Exchange is an amount equal to the higher of:

a. 105 per cent. of the average market value of the Company's Ordinary Shares as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which such share is contracted to be purchased; and

b. In order to benefit from the exemption laid down in Article 5(1) of Regulation (EU) No 596/2014, the Company will not purchase shares at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out, however the Company may exceed these levels in situations of low liquidity; and

2) the aggregate number of ordinary shares which may be acquired on behalf of the Company in connection with the Programme shall not exceed 17,313,523 ordinary shares.

Due to the limited liquidity in the ordinary shares, a buy-back of ordinary shares pursuant to the Programme on any trading day is likely to represent a significant proportion of the daily trading volume in the ordinary shares on the London Stock Exchange (and is likely to exceed the 25% limits of the average daily trading volume as laid down in Article 5(1) of Regulation (EU) No 596/2014 and as such the Company will not benefit from this exemption).

The average daily volume will be calculated based on the 20 trading days preceding the date of purchase required under Article 3(3) of the Commission Delegated Regulation (EU) 2016/1052 dated 8 March 2016.

The Company will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. To the extent permitted by law, ordinary shares bought back under the Programme will be held as treasury shares.

 

For further information, please contact:

 

Nicholas Wilson

+44 (0) 1624 622 851

Qatar Investment Fund plc

Ian Dungate/Suzanne Jones

+44 (0) 1624 692600

Galileo Fund Services Limited

Richard Gray/Andrew Potts

+44 (0) 20 7886 2500

Panmure Gordon

William Clutterbuck/Robbie Hynes

+44 (0) 20 7379 5151

Maitland

 

 

-ENDS-

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSEAKAFADFXEFF
Date   Source Headline
11th Aug 20237:00 amRNSNet Asset Value(s)
10th Aug 20234:30 pmRNSNotification of Major Holdings
8th Aug 20233:30 pmRNSIssue of Equity
8th Aug 20239:00 amRNSNet Asset Value(s)
1st Aug 20239:00 amRNSNet Asset Value(s)
31st Jul 20234:00 pmRNSIssue of Equity
25th Jul 20239:00 amRNSNet Asset Value(s)
24th Jul 20234:30 pmRNSIssue of Equity
20th Jul 20233:30 pmRNSIssue of Equity
19th Jul 20233:00 pmRNSIssue of Equity
18th Jul 20239:00 amRNSNet Asset Value(s)
13th Jul 20233:30 pmRNSQuarterly Report to 30 June 2023
12th Jul 20233:30 pmRNSIssue of Equity
11th Jul 20239:00 amRNSNet Asset Value(s)
4th Jul 20239:00 amRNSNet Asset Value(s)
27th Jun 20234:00 pmRNSNotification of Major Holdings
27th Jun 20239:00 amRNSNet Asset Value(s)
20th Jun 20239:00 amRNSNet Asset Value(s)
16th Jun 202312:00 pmRNSIssue of Equity
13th Jun 20234:30 pmRNSIssue of Equity
13th Jun 20239:00 amRNSNet Asset Value(s)
6th Jun 20234:00 pmRNSIssue of Equity
6th Jun 20239:00 amRNSNet Asset Value(s)
2nd Jun 20234:30 pmRNSIssue of Equity
1st Jun 20231:00 pmRNSIssue of Equity
30th May 20239:19 amRNSNet Asset Value(s)
23rd May 20237:00 amRNSNet Asset Value(s)
16th May 20239:00 amRNSNet Asset Value(s)
9th May 202310:00 amRNSNet Asset Value(s)
2nd May 20239:30 amRNSNet Asset Value(s)
25th Apr 20239:00 amRNSNet Asset Value(s)
21st Apr 202311:00 amRNSCompletion of Tender Offer
18th Apr 202311:05 amRNSUpdate research from QuotedData
18th Apr 20239:00 amRNSNet Asset Value(s)
14th Apr 202311:00 amRNSTender Offer Update - Final Price
13th Apr 202312:00 pmRNSQuarterly Report to 31 March 2023
12th Apr 20239:00 amRNSNet Asset Value(s)
11th Apr 20231:30 pmRNSResults of Tender Offer
4th Apr 20239:00 amRNSNet Asset Value(s)
28th Mar 20239:00 amRNSNet Asset Value(s)
23rd Mar 20237:00 amRNSTender Offer
21st Mar 20239:00 amRNSNet Asset Value(s)
14th Mar 20239:00 amRNSNet Asset Value(s)
7th Mar 20239:00 amRNSNet Asset Value(s)
28th Feb 20239:00 amRNSNet Asset Value(s)
23rd Feb 20237:00 amRNSHalf-year Report
21st Feb 20239:00 amRNSNet Asset Value(s)
14th Feb 20239:00 amRNSNet Asset Value(s)
7th Feb 20239:00 amRNSNet Asset Value(s)
2nd Feb 20237:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.